IAS Calls For Global Access As Gilead Announces Lenacapavir Licensing

“The licensing agreements enabling generic versions of the HIV prevention drug, lenacapavir, in certain countries is an important step forward, but large parts of the world remain excluded, including countries where trials were conducted,” IAS ...